MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy-Reference-Cited by-同舟云学术

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Published:2013-05-28 Issue:10 Volume:98 Page:1554-1562
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Valera A.,Lopez-Guillermo A.,Cardesa-Salzmann T.,Climent F.,Gonzalez-Barca E.,Mercadal S.,Espinosa I.,Novelli S.,Briones J.,Mate J. L.,Salamero O.,Sancho J. M.,Arenillas L.,Serrano S.,Erill N.,Martinez D.,Castillo P.,Rovira J.,Martinez A.,Campo E.,Colomo L.,

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC Rearrangement Prediction from LYSA Whole Slide Images in Large B-cell Lymphoma: A Multi-centric Validation of Self-supervised Deep Learning Models;Modern Pathology;2024-09

2. Immunohistochemistry-based investigation of MYC, BCL2, and Ki-67 protein expression and their clinical impact in diffuse large B-cell lymphoma in upper Northern Thailand;PLOS ONE;2024-07-22

3. Expression and Clinical Significance of Ki-67, CD10, BCL6, MUM1, c-MYC, and EBV in Diffuse Large B Cell Lymphoma Patients;Applied Immunohistochemistry & Molecular Morphology;2024-06-14

4. Increased CCL2/CCR2 axis promotes tumor progression by increasing M2 macrophages in MYC/BCL2 double-expressor diffuse large B-cell lymphoma;2024-04-10

5. An assessment model for efficacy of patients with relapsed or refractory diffuse large B-cell lymphoma following autologous CD19 chimeric antigen receptor T-cell therapy.;2023-12-14